Experts from the Orthopaedic Surgical Manufacturers Association (OSMA) are concerned about the up-classification of some spinal fusion devices from class IIb under the former medical devices directive to class III under the new Medical Device Regulation, based on an interpretation of Rule 8 of the MDR by the guidance document MDCG 2021-24.
For some products, this up-classification has already resulted, or will result, in “significant burden, both administrative and evidentiary,” which is
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?